432 related articles for article (PubMed ID: 28100744)
1. Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.
Li MH; Suchland KL; Ingram SL
J Neurosci; 2017 Jan; 37(3):626-636. PubMed ID: 28100744
[TBL] [Abstract][Full Text] [Related]
2. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro.
Vaughan CW; McGregor IS; Christie MJ
Br J Pharmacol; 1999 Jun; 127(4):935-40. PubMed ID: 10433501
[TBL] [Abstract][Full Text] [Related]
5. Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist.
Meng ID; Johansen JP
Neuroscience; 2004; 124(3):685-93. PubMed ID: 14980738
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Valenzano KJ; Tafesse L; Lee G; Harrison JE; Boulet JM; Gottshall SL; Mark L; Pearson MS; Miller W; Shan S; Rabadi L; Rotshteyn Y; Chaffer SM; Turchin PI; Elsemore DA; Toth M; Koetzner L; Whiteside GT
Neuropharmacology; 2005 Apr; 48(5):658-72. PubMed ID: 15814101
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
Szabo B; Siemes S; Wallmichrath I
Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
[TBL] [Abstract][Full Text] [Related]
8. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
9. GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostral ventromedial medulla.
Li MH; Suchland KL; Ingram SL
J Physiol; 2015 Jan; 593(1):217-30. PubMed ID: 25556797
[TBL] [Abstract][Full Text] [Related]
10. Administrations of thalidomide into the rostral ventromedial medulla produce antinociceptive effects in a rat model of postoperative pain.
Song T; Ma X; Ma P; Gu K; Zhao J; Yang Y; Jiang B; Li Y; Wang C
J Neurosci Res; 2018 Feb; 96(2):273-283. PubMed ID: 28758232
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid CB
Li AL; Carey LM; Mackie K; Hohmann AG
J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
Hofmann ME; Bhatia C; Frazier CJ
J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
[TBL] [Abstract][Full Text] [Related]
13. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.
Palazzo E; Luongo L; Bellini G; Guida F; Marabese I; Boccella S; Rossi F; Maione S; de Novellis V
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):148-61. PubMed ID: 22483283
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
15. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
Choong KC; Su X; Urban MO
Neurosci Lett; 2007 Mar; 414(2):105-9. PubMed ID: 17194542
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
[TBL] [Abstract][Full Text] [Related]
17. Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception.
Hamity MV; White SR; Hammond DL
Neuroscience; 2010 Feb; 165(3):902-13. PubMed ID: 19892001
[TBL] [Abstract][Full Text] [Related]
18. The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner.
Su BX; Chen X; Huo J; Guo SY; Ma R; Liu YW
Brain Res; 2017 Sep; 1671():85-92. PubMed ID: 28716633
[TBL] [Abstract][Full Text] [Related]
19. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
20. Changes in the disposition of substance P in the rostral ventromedial medulla after inflammatory injury in the rat.
Maduka UP; Hamity MV; Walder RY; White SR; Li Y; Hammond DL
Neuroscience; 2016 Mar; 317():1-11. PubMed ID: 26762802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
